Skip to main content

Advertisement

SpringerLink
Log in

Remission of Type 2 Diabetes Mellitus Should Not Be the Foremost Goal after Bariatric Surgery

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Remission of type 2 diabetes (T2D) is a desired outcome after bariatric surgery (BS). Even if this goal is not achieved, individuals who do not strictly fulfill remission criteria experience an overall improvement. The aim of this study was to evaluate the metabolic control status in patients considered as diabetes “non-remitters.”

Methods

A retrospective study of 125 patients (59.2 % women) with preoperative diagnosis of T2D who underwent BS in a single center (2006–2011) was conducted. We collected anthropometric and metabolic parameters before surgery and at 1-year follow-up. T2D remission was defined according to the 2009 consensus statement: glycosylated hemoglobin (HbA1c) <6 %, fasting glucose (FG) <100 mg/dLs, and absence of pharmacologic treatment. We evaluated metabolic status of non-remitters, according to the American Diabetes Association's (ADA) target recommendations: HbA1c <7 %, LDL-c <100 mg/dL, triglycerides <150 mg/dL, and HDL-c >40 (male) or >50 mg/dL (female). Statistics: analysis of variance.

Results

Baseline characteristics (mean ± SD): age 53.5 ± 9.7 years, BMI 43.5 ± 5.6 kg/m2, time since diagnosis of T2D 7.7 ± 7.9 years, FG 162.0 ± 56.3 mg/dL, HbA1c 7.7 ± 1.6 %. ADA's target recommendations were present in 12 patients (9.6 %) preoperatively, and in 45 (36.0 %) at 1-year follow-up (p <0.001). Sixty-two (49.6 %) patients did not achieve diabetes remission; 26 (41.9 %) had now diet treatment, 30 (48.4 %) oral medications, and 6 (9.7 %) required insulin. Of the non-remitters, 57 (91.9 %) had HbA1c <7 % and 18 (40.0 %) achieved ADA's target recommendations. There were no differences between remitters and non-remitters in the number of individuals reaching ADA's combined metabolic control.

Conclusions

Although almost 50 % of the patients may not be classified as diabetes remitters, their significant improvement in metabolic control should be regarded as a success, according to most scientific societies' target recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23.

    Article  PubMed  CAS  Google Scholar 

  2. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.

    Article  PubMed  Google Scholar 

  3. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.

    Article  PubMed  CAS  Google Scholar 

  4. Schauer P, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Eng J Med. 2012;366:1567–76.

    Article  CAS  Google Scholar 

  5. Blackstone R, Bunt JC, Cortés MC, et al. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status. Surg Obes Relat Dis. 2012;8:548–55.

    Article  PubMed  Google Scholar 

  6. Ramos-Levi AM, Cabrerizo L, Matía P, et al. Which criteria should be used to define type 2 diabetes remission after bariatric surgery? BMC Surg. 2013;13:8.

    Article  PubMed  Google Scholar 

  7. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.

    Article  PubMed  Google Scholar 

  8. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.

    Article  PubMed  Google Scholar 

  9. Keogh JB, Turner KM, McDonald F, et al. Remission of diabetes in patients with long-standing type 2 diabetes following placement of adjustable gastric band: a retrospective case control study. Diabetes Obes Metab. 2012. doi:10.1111/dom.12034.

    PubMed  Google Scholar 

  10. Dorman RB, Serrot FJ, Miller CJ, et al. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient. Ann Surg. 2012;255:287–93.

    Article  PubMed  Google Scholar 

  11. Kashyap SR, Schauer P. Clinical considerations for the management of residual diabetes following bariatric surgery. Diabetes Obes Metab. 2012;14:733–79.

    Article  Google Scholar 

  12. Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable diabetes remission of diabetes after Roux –en-Y gastric bypass. Surg Obes Relat Dis. 2010;6:254–9.

    Article  PubMed  Google Scholar 

  13. American Diabetes Association. Position Statement. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36 suppl 1:S67–74.

    Article  Google Scholar 

  14. Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13:159–60.

    Article  PubMed  Google Scholar 

  15. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267–82.

    Article  PubMed  CAS  Google Scholar 

  16. Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre E, et al. Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17:1614–8.

    Article  PubMed  Google Scholar 

  17. American Diabetes Association. Standards of medical care in diabetes 2013 (position statement). Diabetes Care. 2013;36 suppl 1:S11–66.

    Article  Google Scholar 

  18. Pournaras DJ, Aasheim ET, Søvik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012;99:100–3.

    Article  PubMed  CAS  Google Scholar 

  19. Ramos-Levi AM, Sánchez-Pernaute A, Matía P, et al. Rubio MA. Obes Surg: Diagnosis of diabetes remission after bariatric surgery may be jeopardized by remission criteria and previous hypoglycemic treatment; 2013. doi:10.1007/s11695-013-0995-y.

    Google Scholar 

  20. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467–85.

    PubMed  Google Scholar 

  21. Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013;36:20–6.

    Article  PubMed  CAS  Google Scholar 

  22. Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20:1245–50.

    Article  PubMed  Google Scholar 

  23. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50. discussion 350–2.

    Article  PubMed  CAS  Google Scholar 

  24. Rubino F, Schauer PR, Kaplan LM, et al. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393–411.

    Article  PubMed  CAS  Google Scholar 

  25. Lecube A, Burgera B, Rubio MA. Breaking therapeutic inertia: should metabolic surgery be considered one more option for the treatment of type 2 diabetes mellitus? Endocrinol Nutr. 2012;59:281–3.

    Article  PubMed  Google Scholar 

  26. Zimmet P, Alberti KG, Rubino F, et al. IDF's view of bariatric surgery in type 2 diabetes. Lance. 2011;378:108–10.

    Article  Google Scholar 

  27. Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28:628–42.

    Article  PubMed  CAS  Google Scholar 

  28. Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21:794–6.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge grant support from the Fundación Mutua Madrileña de Investigación Biomédica AP 89592011.

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Endocrinology and Nutrition, Facultad de Medicina, Complutense University, C/Prof. Martin Lagos s/n. 28040, Madrid, Spain

    Ana M. Ramos-Levi, Lucio Cabrerizo, Pilar Matia, Ana Barabash, Alfonso L. Calle-Pascual & Miguel A. Rubio

  2. Department of Surgery, Facultad de Medicina, Complutense University, C/Prof. Martin Lagos s/n. 28040, Madrid, Spain

    Andres Sanchez-Pernaute, Carmen Hernandez & Antonio J. Torres

  3. Hospital Clinico San Carlos. Instituto de Investigación Sanitaria San Carlos (IdISSC), Facultad de Medicina, Complutense University, C/Prof. Martin Lagos s/n, 28040, Madrid, Spain

    Miguel A. Rubio

Authors
  1. Ana M. Ramos-Levi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andres Sanchez-Pernaute
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lucio Cabrerizo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pilar Matia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Barabash
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carmen Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alfonso L. Calle-Pascual
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Antonio J. Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Miguel A. Rubio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miguel A. Rubio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramos-Levi, A.M., Sanchez-Pernaute, A., Cabrerizo, L. et al. Remission of Type 2 Diabetes Mellitus Should Not Be the Foremost Goal after Bariatric Surgery. OBES SURG 23, 2020–2025 (2013). https://doi.org/10.1007/s11695-013-1032-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-013-1032-x

Keywords

Search

Navigation